Squarepoint’s Vigil Neuroscience VIGL Stock Holding History

Squarepoint’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-286,980	Closed	-$2.28M	–	5050
2025 Q2	$2.28M	Buy	286,980 +176,029	+159%	+$789K	﹤0.01%	2006
2025 Q1	$197K	Sell	110,951 -2,645	-2%	-$5.94K	﹤0.01%	4019
2024 Q4	$193K	Buy	+113,596	New	+$335K	﹤0.01%	4486
2022 Q2	–	Sell	-86,193	Closed	-$606K	–	3415
2022 Q1	$606K	Buy	+86,193	New	+$1.14M	﹤0.01%	1893

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Squarepoint's VIGL Position: Q3 2025 in Review

Squarepoint sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 286,980 shares — an estimated $2.28M sold.

Squarepoint first reported a position in VIGL in Q1 2022 and held it in 4 quarters. The position peaked at $2.28M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Squarepoint reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 286,980 Vigil Neuroscience shares in Q3 2025, an estimated $2.28M.
Squarepoint first reported a position in Vigil Neuroscience in Q1 2022 and held it in 4 quarters.
Squarepoint's Vigil Neuroscience position peaked at $2.28M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.